Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerlanda Vella

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular Oncology|September 4, 2025
The tumor-microbe connectionGerlanda Vella, Maria Rescigno
Immunity|October 18, 2018
Where Have All the T Cells Gone?Gerlanda Vella, Gabriele Bergers
EMBO Reports|May 28, 2025
Cancer microbiota: a focus on tumor-resident bacteriaGerlanda Vella, Maria Rescigno
Cytokine & Growth Factor Reviews|June 21, 2017
Targeting the tumor and its associated stroma: One and one can make three in adoptive T cell therapy of solid tumorsAnna Mondino, Gerlanda Vella, Laura Icardi
Frontiers in Immunology|September 6, 2021
High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in CancerGerlanda Vella, Sophie Guelfi, Gabriele Bergers
Cancer Cell|February 24, 2023
High endothelial venules in cancer: Regulation, function, and therapeutic implicationGerlanda Vella, Yichao Hua, Gabriele Bergers
Genes and Immunity|March 25, 2026
Trub1-mediated pseudouridylation is dispensable for immune cell development and homeostasisVanshika Malviya, Cuong Thi Pham, Lauren Michiels, et al.
Science Advances|October 24, 2025
Murine vascular organoids are responsive and adaptable 3D systems with cellular heterogeneity and dynamic plasticitySophie Guelfi, Krish Skandha Gopalan, Pieter Maene, et al.
Cancer Cell|November 24, 2022
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1<sup>+</sup> T lymphocyte niches through a feed-forward loopYichao Hua, Gerlanda Vella, Florian Rambow, et al.
Cancer Cell|January 10, 2023
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1<sup>+</sup> T lymphocyte niches through a feed-forward loopYichao Hua, Gerlanda Vella, Florian Rambow, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Oncology|September 4, 2025
The tumor-microbe connectionGerlanda Vella, Maria Rescigno
Immunity|October 18, 2018
Where Have All the T Cells Gone?Gerlanda Vella, Gabriele Bergers
EMBO Reports|May 28, 2025
Cancer microbiota: a focus on tumor-resident bacteriaGerlanda Vella, Maria Rescigno
Cytokine & Growth Factor Reviews|June 21, 2017
Targeting the tumor and its associated stroma: One and one can make three in adoptive T cell therapy of solid tumorsAnna Mondino, Gerlanda Vella, Laura Icardi
Frontiers in Immunology|September 6, 2021
High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in CancerGerlanda Vella, Sophie Guelfi, Gabriele Bergers
Cancer Cell|February 24, 2023
High endothelial venules in cancer: Regulation, function, and therapeutic implicationGerlanda Vella, Yichao Hua, Gabriele Bergers
Genes and Immunity|March 25, 2026
Trub1-mediated pseudouridylation is dispensable for immune cell development and homeostasisVanshika Malviya, Cuong Thi Pham, Lauren Michiels, et al.
Science Advances|October 24, 2025
Murine vascular organoids are responsive and adaptable 3D systems with cellular heterogeneity and dynamic plasticitySophie Guelfi, Krish Skandha Gopalan, Pieter Maene, et al.
Cancer Cell|November 24, 2022
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1<sup>+</sup> T lymphocyte niches through a feed-forward loopYichao Hua, Gerlanda Vella, Florian Rambow, et al.
Cancer Cell|January 10, 2023
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1<sup>+</sup> T lymphocyte niches through a feed-forward loopYichao Hua, Gerlanda Vella, Florian Rambow, et al.
Pageof 2